Northern Trust Corp Kezar Life Sciences, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 90,385 shares of KZR stock, worth $674,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,385

Previous 449,778 79.9%

Holding current value

$674,272

Previous $269,000 74.35%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.53 - $0.77 $190,478 - $276,732	-359,393 Reduced 79.9%	90,385 $69,000
Q2 2024 Aug 14, 2024	SELL	$0.6 - $0.92 $39,351 - $60,338	-65,585 Reduced 12.73%	449,778 $269,000
Q1 2024 May 14, 2024	SELL	$0.8 - $1.05 $22,482 - $29,508	-28,103 Reduced 5.17%	515,363 $463,000
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.15 $18,952 - $30,271	-26,323 Reduced 4.62%	543,466 $516,000
Q3 2023 Nov 13, 2023	BUY	$1.08 - $2.54 $12,539 - $29,491	11,611 Added 2.08%	569,789 $678,000
Q2 2023 Aug 11, 2023	SELL	$2.31 - $3.06 $915,360 - $1.21 Million	-396,260 Reduced 41.52%	558,178 $1.37 Million
Q1 2023 May 15, 2023	SELL	$3.13 - $7.31 $80,350 - $187,655	-25,671 Reduced 2.62%	954,438 $2.99 Million
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $22,863 - $31,486	3,578 Added 0.37%	980,109 $6.9 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $399,595 - $537,629	50,012 Added 5.4%	976,531 $8.41 Million
Q2 2022 Aug 12, 2022	BUY	$4.58 - $17.13 $2.24 Million - $8.38 Million	489,086 Added 111.81%	926,519 $7.66 Million
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $256,590 - $382,382	20,861 Added 5.01%	437,433 $7.27 Million
Q4 2021 Feb 08, 2022	SELL	$7.44 - $16.72 $48,166 - $108,245	-6,474 Reduced 1.53%	416,572 $6.97 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $9.73 $98,527 - $197,664	-20,315 Reduced 4.58%	423,046 $3.65 Million
Q2 2021 Aug 13, 2021	BUY	$4.93 - $6.46 $623,413 - $816,886	126,453 Added 39.9%	443,361 $2.41 Million
Q1 2021 May 12, 2021	SELL	$5.24 - $6.99 $117,019 - $156,100	-22,332 Reduced 6.58%	316,908 $1.89 Million
Q4 2020 Feb 11, 2021	SELL	$4.77 - $6.58 $57,926 - $79,907	-12,144 Reduced 3.46%	339,240 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$4.36 - $5.5 $187,589 - $236,637	43,025 Added 13.95%	351,384 $1.7 Million
Q2 2020 Aug 14, 2020	SELL	$3.6 - $7.75 $90,828 - $195,532	-25,230 Reduced 7.56%	308,359 $1.6 Million
Q1 2020 May 14, 2020	BUY	$2.77 - $5.75 $527,801 - $1.1 Million	190,542 Added 133.2%	333,589 $1.46 Million
Q4 2019 Feb 14, 2020	SELL	$2.5 - $4.26 $23,417 - $39,903	-9,367 Reduced 6.15%	143,047 $574,000
Q3 2019 Nov 13, 2019	BUY	$3.0 - $7.58 $58,578 - $148,007	19,526 Added 14.69%	152,414 $500,000
Q2 2019 Aug 13, 2019	BUY	$7.09 - $21.9 $41,703 - $128,815	5,882 Added 4.63%	132,888 $1.03 Million
Q1 2019 May 13, 2019	BUY	$16.83 - $23.75 $1.18 Million - $1.66 Million	70,013 Added 122.84%	127,006 $2.25 Million
Q4 2018 Feb 12, 2019	BUY	$20.21 - $32.9 $92,582 - $150,714	4,581 Added 8.74%	56,993 $1.35 Million
Q3 2018 Nov 14, 2018	BUY	$15.5 - $21.41 $812,386 - $1.12 Million	52,412 New	52,412 $1.12 Million

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $510M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Kezar Life Sciences, Inc. Transaction History